<!doctype html><html><title>Booster Timeline</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=stylesheet href=/css/style.css><link rel=stylesheet href=/css/media.css><body><div class=content><div class="container m-auto"><div class="w-md-55 m-auto mt-2 text-center"><a class="title text-black text-decoration-none" href=/>Booster Timeline</a></div></div><div class="container content m-auto"><div id=article class="w-md-55 m-auto"><div class="mt-1 article-title text-capitalize-letter">Tweets by Eric Topol</div><div class="mt-2 italic post-date">Sep 17, 2021</div><div class="mt-2 article"><div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1438854121864400902 target=_blank rel=noreferer>06:15 UCT-7</a></div><div class=content>Just published @NatureRevGenet<p>A tour de force review of the #SARSCoV2 variants</p><p><a href=https://www.nature.com/articles/s41576-021-00408-x target=_blank rel=noreferer><a href=https://www.nature.com/articles/s41576-021-00408-x>https://www.nature.com/articles/s41576-021-00408-x</a></a></p></div><a href=/twitter/erictopol/images/E_fV2TNVIAIKiAc.jpg><img src=/twitter/erictopol/images/E_fV2TNVIAIKiAc.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_fWGH7VkAMmAyG.jpg><img src=/twitter/erictopol/images/E_fWGH7VkAMmAyG.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_fWJxfVIAI3RNY.jpg><img src=/twitter/erictopol/images/E_fWJxfVIAI3RNY.jpg alt="Twitter image"></img></a></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1438858008059023366 target=_blank rel=noreferer>06:30 UCT-7</a></div><div class=content>A new @ONS UK report on #LongCovid frequency and duration in ~50,000 people, half w/ infections, half controls, and multiple types of assessment<p><a href=https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021 target=_blank rel=noreferer><a href=https://www.ons.gov.uk/peoplepopulationandcommunit>https://www.ons.gov.uk/peoplepopulationandcommunit</a> &mldr;</a></p><p>Unusual in children; increase in women, middle-age, high viral load (Ct). Overall lower % than previous reports</div><a href=/twitter/erictopol/images/E_fY5h2UcAIZpF9.png><img src=/twitter/erictopol/images/E_fY5h2UcAIZpF9.png alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_fZOvfVUAQhpdA.png><img src=/twitter/erictopol/images/E_fZOvfVUAQhpdA.png alt="Twitter image"></img></a></div></p><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1438863985810415620 target=_blank rel=noreferer>06:54 UCT-7</a></div><div class=content>RT @matthewherper: This current discussion from the CDC on collecting data about the vaccines just reveals how terrible the U.S. collection‚Ä¶</div></div><div class=thread><div class=thread-content>New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised people, March-August <a href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7038e1.htm?s_cid=mm7038e1_w" target=_blank rel=noreferer>https://www.cdc.gov/mmwr/volumes/70/wr/mm7038e1.ht ...</a><p>Vaccine Effectiveness vs H:</p><p>Moderna 93%, Pfizer 88%, J&J 71%</p><p>See Table below for details, Figure for Ab response</div><a href=/twitter/erictopol/images/E_gQtvjUYAIVYgC.jpg><img src=/twitter/erictopol/images/E_gQtvjUYAIVYgC.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_gRBBwVgAAVL4r.jpg><img src=/twitter/erictopol/images/E_gRBBwVgAAVL4r.jpg alt="Twitter image"></img></a><hr><div class=thread-content>Note Pfizer&rsquo;s data after 120 days reduction of vaccine effectiveness vs hospitalization 91% (88-93) to 77% (67-84). That is statistically significant and not trivial.</div></p><hr><div class=profile><a href=https://twitter.com/erictopol/status/1438921818069364739 target=_blank rel=noreferer>10:44 UCT-7</a></div><div class=content>These US IVY network data and much more (including July/August timing) were not part of today's @US_FDA VRBPAC and Monday's ACIP Pfizer booster review. That is unfortunate with continued assertions by many that there is fully preserved vaccine protection from hospitalizations</div></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1438940885861896193 target=_blank rel=noreferer>12:00 UCT-7</a></div><div class=content>Agree with this call with a qualifier.<p>Not &ldquo;probably.&rdquo;</p><p>Age ‚â• 60. There is unequivocal benefit of the 3rd shot.</p><p>Need further data for making the decision on younger age groups. <a href=https://t.co/LIRtdV8ZXh>https://t.co/LIRtdV8ZXh</a></div></p></div><div class=thread><div class=thread-content>The vote question was set up to fail, calling for a blanket approval for all age 16+ (related to aggressive Pfizer EUA request). How could that possibly be voted for in favor when such broad data do not exist anywhere?<p>Of course, the vote was 16 to 3 against.</div><a href=/twitter/erictopol/images/E_gtJ9-WQAoc1K2.jpg><img src=/twitter/erictopol/images/E_gtJ9-WQAoc1K2.jpg alt="Twitter image"></img></a><hr><div class=profile><a href=https://twitter.com/erictopol/status/1438956370342993921 target=_blank rel=noreferer>13:01 UCT-7</a></p></div><div class=content>There will be a new question, likely with the age 60 cutoff, that is likely to get near unanimous support.<p>(Reminder: The UK went ahead with an age 50 cutoff this week for all vaccines).</p><p>Left unaddressed is the vulnerable frontline health care workforce</div></p></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1438970304785629188 target=_blank rel=noreferer>13:57 UCT-7</a></div><div class=content>RT @ashishkjha: And unanimous on including healthcare workers in the EUA<p>All good stuff</div></p></div><div class=thread><div class=thread-content>Now a unanimous vote in favor of 65 and older and people at high-risk for severe covid (which gives room for interpretation). OK, that's progress. üëç https://t.co/G2l8fxAolY</div><hr><div class=profile><a href=https://twitter.com/erictopol/status/1438974306579484673 target=_blank rel=noreferer>14:13 UCT-7</a></div><div class=content>A very good outcome for this FDA Advisory Committee following what data are available w/r to age, and recognizing the need for high-risk individuals, due to co-existing conditions or occupational exposures, such as the heathcare workforce, essential workers, and teachers.<p>üëãüôè</div></p></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1438979986333995009 target=_blank rel=noreferer>14:35 UCT-7</a></div><div class=content>A new, outstanding review of Covid-19 @Sciimmunology on how we can favorably modulate the immune response in people, learning from bats, which get only mild disease from #SARSCoV2 <a href=https://www.science.org/doi/10.1126/sciimmunol.abd0205 target=_blank rel=noreferer>https://www.science.org/doi/10.1126/sciimmunol.abd ...</a></div><a href=/twitter/erictopol/images/E_hIU5cVcAAKJIV.jpg><img src=/twitter/erictopol/images/E_hIU5cVcAAKJIV.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_hIHgXVgAMpdy_.jpg><img src=/twitter/erictopol/images/E_hIHgXVgAMpdy_.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_hIKPiVcAUanwj.jpg><img src=/twitter/erictopol/images/E_hIKPiVcAUanwj.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E_hIMoPVgAAu-e1.jpg><img src=/twitter/erictopol/images/E_hIMoPVgAAu-e1.jpg alt="Twitter image"></img></a></div><div class=thread><div class=thread-content>Today‚Äôs FDA Advisory for Pfizer didn‚Äôt address the vulnerability of people who received J&J shots. But these data of low antibody levels üëáfor J&J suggest high vulnerability‚Äîan mRNA vaccine 2nd shot is overdue to be addressed by CDC/FDA and should be supported. https://t.co/hEG9zAnIMz</div><hr><div class=profile><a href=https://twitter.com/erictopol/status/1439045221279420417 target=_blank rel=noreferer>18:54 UCT-7</a></div><div class=content>Part of this vexing rests with J&J. AFAIK they have not submitted to FDA or published any data on this vital question, and we have been extrapolating from the very strong immune response and safety from Astra Zeneca 1st shot, mRNA 2nd (better than either vaccine 2 doses)</div></div></div></div><div class=mt-2></div><div class="mt-4 w-md-80 border-top text-default"><div class="d-md-flex d-flex-space-between"><div class="w-md-40 pt-2"><div class="mb-2 text-medium"><a href=https://science-democracy.github.io/twitter/erictopol/09/16/>Previous</a></div></div><div class="w-md-40-max pt-2"><div class="mb-2 text-medium"><a href=https://science-democracy.github.io/twitter/erictopol/09/18/>Next</a></div></div></div></div></div></div></div><div class="container m-auto"><div class="d-flex d-flex-space-between"><div class=mt-4></div></div></div></body></html>